Skip to content

Study on the skin improvement effects of the cosmetic containing collagen-modified liposomes

Randomized, placebo-controlled, double-blind, split-face comparative study on the skin improvement effects of the cosmetic containing collagen-modified liposomes after wounds healing - KNO-001 study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000038645
Enrollment
30
Registered
2019-12-01
Start date
2020-02-27
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult women scheduled to complete skin laser treatment

Interventions

Apply the test product (skin cosmetic containing a cosmetic base consisting of collagen-modified liposomes) twice a day, and apply an appropriate amount for 6 weeks after wounds healing (after epithel
collagen modified liposome&#39
are removed from the test product, twice a day, and apply an appropriate amount for 6 weeks after wounds healing (after epithelial recovery) following laser treatment.

Sponsors

Kitasato University, school of medicine, Department of Plastic & Aesthetic Surgery
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: (1) Women who can obtain written consent (2) Women who are between 20 and 60 years old when obtaining consent (3) Women with laser treatment target sites on both the left and right sides of the face (4) Women who can go to the hospital according to the study schedule

Exclusion criteria

Exclusion criteria: (1) Persons with histories of allergies to cosmetic (2) Person receiving any hormone replacement therapies (3) Pregnant and breastfeeding women (4) Persons who have experience in cosmetic medicine that affects the evaluation site, or who are scheduled to receive it during the study period (5) Persons who have undergone special skin care (e.g., beauty salon, esthetic salon) for the evaluation site within the past 4 weeks or who are scheduled to receive it during the study period (6) Persons with inflammation or skin disease that affects evaluation (7) Persons who are judged to be inappropriate for participation in this study by the principal investigator or other investigators (hereinafter referred to as the investigators)

Design outcomes

Primary

MeasureTime frame
Measurement of skin moisture (test site): Evaluation is made before application of the test product or placebo, 1 week, 2 weeks, 4 weeks and 6 weeks after the start of application of the test product or placebo.

Secondary

MeasureTime frame
Skin moisture measurement (1 cheek site of each split face) Evaluation of skin findings by doctors Analysis of changes in skin conditions using digital camera images Participant questionnaire Incidence of adverse events Skin moisture measurement and analysis of digital camera images are evaluated before application of the test product or placebo, 1 week, 2 weeks, 4 weeks, and 6 weeks after application of the test product or placebo. The skin findings are evaluated 1 week, 2 weeks, 4 weeks and 6 weeks after the start of application of the test product or placebo. The questionnaire for the participants will be evaluated 2 weeks, 4 weeks and 6 weeks after the start of application of the test product or placebo. In addition, safety will be checked throughout the period.

Countries

Japan

Contacts

Public ContactYoshika Sugimoto

Kitasato University, school of medicine Department of Plastic & Aesthetic Surgery

yoshika_sgy@yahoo.co.jp042-778-9074

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026